segunda-feira, março 14, 2005
Notícias sobre interrupções de tratamento
Individuals who started HAART with a lowest ever CD4 cell count above 250 cells/mm3 and achieved a sustained increase in CD4 cell count above 500 cells/mm3 appear to be able to safely interrupt HIV therapy for over a year, according to an international study published in the February 18th edition of AIDS. It is likely that the investigators’ findings will be viewed with considerable interest by researchers involved in the SMART study into the safety and efficacy of CD4 cell guided treatment interruptions.
(...)
(...)
